Loupakis, Fotios

Loupakis, Fotios  

Mostra records
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.012 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 2017 Galuppini, FrancescaPennelli, GianmariaLoupakis, FotiosLanza, CristianoVianello, LucaSacchi, DianaMescoli, ClaudiaSalmaso, RobertaAgostini, MarcoLonardi, SaraFarinati, FabioRugge, MassimoFassan, Matteo HISTOPATHOLOGY - -
Precision medicine in cholangiocarcinoma 2018 PELLINO, ANTONIOLoupakis, FotiosCadamuro, MassimilianoFassan, MatteoGuido, MariaCillo, UmbertoIndraccolo, StefanoFabris, Luca + TRANSLATIONAL GASTROINTESTINAL CANCER - -
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? 2018 Loupakis, FotiosINTINI, ROSSANABergamo, FrancescaBertorelle, RobertaFassan, MatteoMerigliano, StefanoPilati, PierluigiUrso, Emanuele Luca DamianoCillo, UmbertoRugge, MassimoLonardi, SaraZagonel, Vittorina + THE ONCOLOGIST - -
LONG-NONCODING RNAs in gastroesophageal cancers 2018 Fanelli, Giuseppe NicolòCoati, IreneLoupakis, FotiosCappellesso, RoccoFassan, Matteo + NON-CODING RNA RESEARCH - -
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 2018 Fassan, MatteoVianello, LucaSACCHI, DIANAFanelli, Giuseppe N.MUNARI, GIADACappellesso, RoccoLoupakis, FotiosLanza, CristianoSALMASO, ROBERTAMescoli, ClaudiaAgostini, MarcoD'Angelo, EdoardoLonardi, SaraPucciarelli, SalvatoreVeronese, NicolaRugge, Massimo + CANCER CELL INTERNATIONAL - -
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study 2019 Loupakis, FotiosLonardi, SaraFassan, Matteo + ESMO OPEN - -
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 2019 Lonardi, SaraMunari, GiadaRugge, MassimoMescoli, ClaudiaDei Tos, Angelo PZagonel, VittorinaLoupakis, FotiosFassan, Matteo + CLINICAL CANCER RESEARCH - -
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer 2019 Procaccio, LetiziaDi Antonio, VeronicaFassan, MatteoZagonel, VittorinaLonardi, SaraLoupakis, Fotios + EXPERT REVIEW OF RESPIRATORY MEDICINE - -
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 2019 Fassan, MatteoMescoli, ClaudiaGuzzardo, VincenzaMunari, GiadaLoupakis, FotiosLonardi, SaraD'Angelo, EdoardoPucciarelli, SalvatoreAngriman, ImerioAgostini, MarcoFarinati, FabioRugge, Massimo + TRANSLATIONAL ONCOLOGY - -
Tumor mutation burden: From comprehensive mutational screening to the clinic 2019 Galuppini F.Loupakis F.Fassan M. + CANCER CELL INTERNATIONAL - -
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (Cancer Cell International (2018) 18 (131) DOI: 10.1186/s12935-018-0634-8) 2019 Fassan M.Sacchi D.Fanelli G. N.Cappellesso R.Loupakis F.Lanza C.Mescoli C.Agostini M.Pucciarelli S.Rugge M. + CANCER CELL INTERNATIONAL - -
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives 2019 Pellino A.Riello E.Nappo F.Brignola S.Lonardi S.Zagonel V.Rugge M.Loupakis F.Fassan M. + WORLD JOURNAL OF GASTROENTEROLOGY - -
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 2019 Fanelli G. N.Loupakis F.Lonardi S.Pucciarelli S.Munari G.Rugge M.Fassan M. + INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY - -
PTEN in colorectal cancer: Shedding light on its role as predictor and target 2019 Loupakis F.Fassan M.Bria E.Tortora G. + CANCERS - -
PD-L1 expression in gastroesophageal dysplastic lesions 2019 Fassan M.Brignola S.Pennelli G.ALBERTI, GIULIAPellino A.Lanza C.Salmaso R.Lonardi S.Pucciarelli S.Spolverato G.Farinati F.Rugge M.Loupakis F. + VIRCHOWS ARCHIV - -
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status 2019 Loupakis F.Bergamo F.Dei Tos A. P.Rugge M.Zagonel V.Fassan M. + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 2019 Loupakis F.Intini R.Buggin, FedericaPRETE, ALESSANDRA ANNALonardi S.Zagonel V.Fassan M. + EUROPEAN JOURNAL OF CANCER - -
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 2019 Loupakis F.Prete A. A.Intini R.Guzzardo V.Mescoli C.Lonardi S.Rugge M.Zagonel V.Fassan M. + BRITISH JOURNAL OF CANCER - -
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 2019 Fanelli G. N.Brignola S.Lanza C.Cappellesso R.Pellino A.Pucciarelli S.Spolverato G.Guzzardo V.Zaninotto G.Farinati F.Rugge M.Kiss A.Loupakis F.Fassan M. + BRITISH JOURNAL OF CANCER - -
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 2020 Loupakis, FotiosLonardi, SaraFassan, MatteoValmasoni, Michele + GASTRIC CANCER - -